PubMed · 2011 · 18 citations · 18 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyImmunotherapyCancer ImmunotherapyNatural Killer Cell TherapyPlatelet ActivationPlatelet AggregationPlatelet FunctionPlatelet PhysiologyAscorbate MetabolismAscorbic Acid InhibitionAscorbic Acid PhysiologyAscorbic Acid TreatmentConcentrationPlatelet Aggregation InhibitionPlatelet Inhibition
Platelets aggregation around migrating tumor cells offers protection against the cytotoxic activity of the natural killers cells (NKC). The ascorbic acid in 3 x 10(-3) M concentration completely inhibited platelet aggregation, decreased thromboxane B2 levels, and inhibited the expression of platelet membranic receptor GpIIb/IIIa in non stimulated platelets, and increased the NKC cytotoxicity in an average rate of 105, 61, and 285% in the NKC/targets cells ratios 12.5:1, 25:1 and 50:1 respectively. The results suggest the role of ascorbic acid in increasing the susceptibility of tumor cells to NKC; the ascorbic acid could be used as part of a multidrug therapy to treat diseases which up to now have been treated only through chemotherapy.
18
Interleukin-2 augments natural killer cell activity
Christopher S. Henney, Kagemasa Kuribayashi, D E Kern et al. · Nature · 1981 · 922 citations
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
Bernhard Nieswandt, Michael Häfner, Bernd Echtenacher et al. · PubMed · 1999 · 838 citations
Life Sciences, Immunology, Oncology +13
Specific and nonspecific NK cell activation during virus infection
Ayotunde O. Dokun, Sung‐Jin Kim, Hamish R.C. Smith et al. · Nature Immunology · 2001 · 468 citations
Simona Neri, Erminia Mariani, Alessandra Meneghetti et al. · Clinical and Diagnostic Laboratory Immunology · 2001 · 318 citations · Full text